Société Calidi Biotherapeutics, Inc.
Actions
CLDI
US3207031010
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,232 USD | -2,93% | +15,42% | -84,64% |
21/03 | CALIDI BIOTHERAPEUTICS, INC. : Opinion positive de HC Wainwright | ZM |
07/02 | Mise à jour sectorielle : Les actions du secteur de la santé plus fermes en fin d'après-midi | MT |
Métier
Nombre d'employés: 41
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Allan Camaisa
CEO | Chief Executive Officer | - | - |
Andrew Jackson
DFI | Director of Finance/CFO | 55 | 30/10/23 |
Amish A. Patel
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/08/22 |
Chief Tech/Sci/R&D Officer | 45 | - | |
Wendy Pizarro
ADM | Chief Administrative Officer | 53 | - |
Boris Minev
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
George Ng
BRD | Director/Board Member | 49 | 01/10/19 |
Stephen Thesing
IRC | Investor Relations Contact | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
George Ng
BRD | Director/Board Member | 49 | 01/10/19 |
Alan Stewart
BRD | Director/Board Member | 60 | 10/10/23 |
James Schoeneck
BRD | Director/Board Member | 66 | - |
Allan Camaisa
CEO | Chief Executive Officer | - | - |
Scott Leftwich
BRD | Director/Board Member | - | - |
David LaPré
BRD | Director/Board Member | - | 01/01 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 35 726 784 | 16 092 971 ( 45,04 %) | 0 | 45,04 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-84,64% | 11,7 M | |
+2,97% | 108 Md | |
+10,21% | 105 Md | |
+1,57% | 23,46 Md | |
-12,77% | 21,72 Md | |
-7,05% | 18,64 Md | |
-37,64% | 17,45 Md | |
-6,50% | 17,19 Md | |
+6,00% | 13,99 Md | |
+37,20% | 12,53 Md |
- Bourse
- Actions
- Action CLDI
- Société Calidi Biotherapeutics, Inc.